Compare Stocks → Better than Bitcoin? The Biotech Stock with 46,751% Potential (From Behind the Markets) (Ad) Compare stocks and their fundamentals, performance, price, and technicals. Use this free stock comparison tool to evaluate companies based on their analyst ratings, book value, debt, dividend, MarketRank, news sentiment, price performance, profitability, and more. Enter up to ten stock symbols separated by a comma or space (ex. BAC, JPM, WFC, C, GS). Comparison Ideas Agriculture StocksAirline StocksApparel StocksArtificial Intelligence StocksAutomotive StocksBank StocksBitcoin StocksBlockchain StocksCanadian StocksCannabis StocksCasino StocksChatGPT StocksChinese StocksCloud Storage StocksCoronavirus Therapeutics StocksCryptocurrency StocksCybersecurity StocksDefense StocksDividend StocksDow 30 StocksEcommerce StocksElectric Vehicles StocksEnergy StocksEntertainment StockseSports StocksEV Charging StocksFertilizer StocksGold StocksGrocery StocksGrowth StocksHealthcare StocksHigh Dividend StocksHome Office StocksHotel StocksLarge Cap StocksLeisure StocksLithium StocksMagnificent Seven StocksMATANA StocksMega Cap StocksMeme StocksMetaverse StocksMid Cap StocksMining StocksMusic Industry StocksNanotechnology StocksNFT StocksOil StocksOutdoor Activities StocksPharmaceutical StocksRenewable Energy StocksRestaurant StocksRetail StocksSemiconductor StocksSocial Media StocksSolar StocksSpace StocksStay-At-Home StocksTechnology StocksTelecom StocksToy StocksUtility StocksVaccine StocksVideo Game StocksVirtual Reality StocksWallStreetBets Stocks Stocks to Compare Sections All Sections Selected Performance Chart Price & Volume MarketRank Analyst Ratings Sales & Book Value Profitability & Earnings Dividends Debt Ownership Miscellaneous Headlines About Compare Share Comparison Share Comparison NASDAQ:SILK Comparative Price Performance Over Time1 day7 days30 days90 days365 daysCompare Stocks - Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeSILKSilk Road Medical$17.80+0.8%$17.52$6.08▼$45.08$697.23M1.48788,862 shs449,135 shs10 Best Stocks to Own in 2024Click the link below and we'll send you MarketBeat's list of the 10 best stocks to own in 2024 and why they should be in your portfolio. Get This Free ReportPrice PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceSILKSilk Road Medical+0.46%+1.32%-7.25%+16.50%-60.15%Protect Yourself While There’s Still Time … (Ad)The next step of the Fed's control is here. Section 702 of the Foreign Intelligence Surveillance Act was renewed for two more years and passed into law earlier this week. Allowing the Fed to tighten its grip on your personal privacy and freedom.4 simple steps to protect your privacy and money before it’s too late.MarketRank™CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & ValuationSILKSilk Road Medical2.5532 of 5 stars2.11.00.04.31.81.70.6Analyst RatingsCompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current PriceSILKSilk Road Medical2.18Hold$22.1824.62% UpsideCurrent Analyst RatingsLatest SILK Analyst RatingsDateCompanyBrokerageActionRatingPrice TargetDetails3/7/2024SILKSilk Road MedicalArgusSubscribe to MarketBeat All Access for the recommendation accuracy ratingUpgradeHold ➝ Buy$24.002/29/2024SILKSilk Road MedicalStifel NicolausSubscribe to MarketBeat All Access for the recommendation accuracy ratingBoost Price TargetBuy ➝ Buy$20.00 ➝ $23.002/29/2024SILKSilk Road MedicalJPMorgan Chase & Co.Subscribe to MarketBeat All Access for the recommendation accuracy ratingBoost Price TargetNeutral ➝ Neutral$10.00 ➝ $19.002/29/2024SILKSilk Road MedicalPiper SandlerSubscribe to MarketBeat All Access for the recommendation accuracy ratingBoost Price TargetNeutral ➝ Neutral$11.00 ➝ $18.00(Data available from 4/26/2021 forward. View 10+ years of historical ratings with our analyst ratings screener.)Sales & Book ValueCompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/BookSILKSilk Road Medical$177.13M3.94N/AN/A$3.88 per share4.59Profitability & EarningsCompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings DateSILKSilk Road Medical-$55.74M-$1.44N/AN/AN/A-31.70%-36.38%-21.41%4/30/2024 (Confirmed)Latest SILK EarningsDateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails4/30/2024N/ASILKSilk Road Medical-$0.40N/A+$0.40N/AN/AN/A 2/28/2024Q4 2023SILKSilk Road Medical-$0.40-$0.33+$0.07-$0.33$42.23 million$47.27 million DividendsCompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive GrowthSILKSilk Road MedicalN/AN/AN/AN/AN/ADebtCompanyDebt-to-Equity RatioCurrent RatioQuick RatioSILKSilk Road Medical0.507.956.97OwnershipInstitutional OwnershipCompanyInstitutional OwnershipSILKSilk Road MedicalN/AInsider OwnershipCompanyInsider OwnershipSILKSilk Road Medical6.70%MiscellaneousCompanyEmployeesShares OutstandingFree FloatOptionableSILKSilk Road Medical47439.17 million36.55 millionOptionableSILK HeadlinesSourceHeadlineFederated Hermes Inc. Acquires Shares of 471,777 Silk Road Medical, Inc (NASDAQ:SILK)marketbeat.com - April 26 at 5:39 AMSilk Road Medical to Present at the BofA Securities 2024 Healthcare Conferenceglobenewswire.com - April 23 at 4:30 PMAll You Need to Know About Silk Road Medical (SILK) Rating Upgrade to Buyzacks.com - April 23 at 1:00 PMSilk Road Medical (SILK) to Release Quarterly Earnings on Tuesdayamericanbankingnews.com - April 23 at 4:32 AMSilk Road Medical (SILK) to Release Earnings on Tuesdaymarketbeat.com - April 23 at 4:30 AMThe Silk Road of the Seasundaytimes.lk - April 22 at 3:28 PMHeard of Zoroastrianism in history class? The ancient religion still has fervent followers.nationalgeographic.com - April 22 at 3:28 PMPeregrine Capital Management LLC Sells 338,639 Shares of Silk Road Medical, Inc (NASDAQ:SILK)marketbeat.com - April 12 at 6:44 AMSilk Road Medical, Inc (NASDAQ:SILK) Receives Consensus Rating of "Hold" from Brokeragesmarketbeat.com - April 12 at 2:17 AMSilk Road Medical (NASDAQ:SILK) Stock Price Up 3.5%marketbeat.com - April 11 at 12:45 PMSilk Road Medical to Report First Quarter 2024 Financial Results on April 30, 2024globenewswire.com - April 9 at 4:30 PMSilk Road Medical's (SILK) New Launch to Aid Its TCAR Portfoliozacks.com - April 8 at 11:25 AMChina, Sri Lanka forging stronger bondschinadaily.com.cn - April 7 at 3:48 PMSilk Road Medical (NASDAQ:SILK) Trading Up 5.1%marketbeat.com - April 5 at 3:45 PMTaiwan Earthquake: What to Know About Travel and How to Helpmsn.com - April 5 at 1:08 AMThe One and Only Benedict Wongvulture.com - April 4 at 7:57 AMSilk Road Medical Launches Enroute Transcarotid NPS Plusevtoday.com - April 4 at 7:57 AMWorker injured by electric shock from power line in Biddefordfinance.yahoo.com - April 3 at 11:54 AMSilk Road launches next-gen transcarotid neuroprotection systemmassdevice.com - April 3 at 11:54 AMAncient People Also Had Sunburns, So They Used These 4 Forms of Protectionmsn.com - April 3 at 6:53 AMTraditional Chinese medicine gains wider recognition around worldsb.by - April 3 at 6:53 AMSilk Road Medical Strengthens TCAR Portfolio with Launch of ENROUTE Transcarotid Neuroprotection System PLUSglobenewswire.com - April 2 at 4:30 PMTurkmenistan to launch traffic on Tejen - Mary expresswayen.trend.az - March 30 at 2:13 PMNumber of Russian Crocus City Hall terrorist attack victims increasesen.trend.az - March 30 at 2:13 PMNew MarketBeat Followers Over TimeMedia Sentiment Over TimeCompany DescriptionsSilk Road MedicalNASDAQ:SILKSilk Road Medical, Inc operates as a medical device company in the United States. The company offers various products for the treatment of carotid artery disease called transcarotid artery revascularization (TCAR). Its products comprise ENROUTE Transcarotid Neuroprotection System that is used to directly access the common carotid artery and establish temporary blood flow reversal; ENROUTE Transcarotid Stent System for transcarotid access; ENHANCE Transcarotid Peripheral Access Kit, which is used to gain initial access to the common carotid artery; ENROUTE 0.014 Guidewire for atraumatic vessel navigation and target lesion crossing for delivery of interventional devices; and ENROUTE Enflate Transcarotid RX Balloon Dilation Catheter, a transcarotid rapid exchange balloon for the TCAR procedure. The company was incorporated in 2007 and is headquartered in Sunnyvale, California. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
